Table 3. Percentage of cells in G0/G1 following incubation with loperamide.

	CTAC	D-17	CML-1	CMT-12
6 hr
0 µM	48.5 ± 3.1	45.8 ± 1.2	54.6 ± 0.3	49.7 ± 1.4
10 µM	50 ± 2	44.5 ± 0.5	55.8 ± 1.2	51.5 ± 2
30 µM	41.3 ± 1.1	44.8 ± 0.6	59.7 ± 1.3	49 ± 2.3
24 hr
0 µM	38.1 ± 3.3	52.6 ± 1.5	50.6 ± 0.3	58.7 ± 1
10 µM	53.5 ± 2.1	55.5 ± 2.2	57.2 ± 1.6	59.6 ± 0.2
30 µM	56.8 ± 0.8*	63.4 ± 3.7*	70 ± 1.9*	78.2 ± 2.4*
48 hr
0 µM	52.7 ± 5.1	54.4 ± 1.2	49.7 ± 3.1	80.4 ± 1.1
10 µM	51.2 ± 1.6	60.7 ± 1.8	50.3 ± 1.8	77.6 ± 2
30 µM	62.8 ± 2.4*	78.8 ± 1.1*	71.6 ± 0.8*	85.7 ± 1.7*

Percentage of cells in G0/G1 at three different time points and three different loperamide concentrations. Values are expressed as mean ± SEM from three independent experiments. An * indicates that there are significantly more G0/G1 cells compared to the control (0 µM of drug) as analyzed via ANOVA with Tukey post-hoc test.